Yeungnam Univ J Med.
2016 Dec;33(2):150-154. 10.12701/yujm.2016.33.2.150.
Chronic hepatitis C healed by peginterferon-α and rivabirin treatment after kidney transplantation
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea. green740@naver.com
- KMID: 2366130
- DOI: http://doi.org/10.12701/yujm.2016.33.2.150
Abstract
- Hepatitis C virus (HCV) infection is present in a high proportion of patients with kidney transplantation. Compared with uninfected kidney transplant recipients, HCV infected kidney recipient have higher prevalence of liver disease and worse allograft survival after transplantation. Interferon monotherapy before transplantation is standard therapy for HCV-infected kidney transplant candidates. If HCV infection is discovered after transplantation, interferon monotherapy is considered due to the limited critical situation. However, in this patient, who was a kidney recipient, HCV infection was treated after kidney transplantation with peginterferon-α and rivabirin. As a result, the patient achieved sustained virologic response.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Features of Retinopathy in Chronic Hepatitis B Patients With Treated With Peginterferon
- Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients
- Peginterferon Alfa-2a on Patients with Chronic Hepatitis C
- Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea
- Permanent sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment
